Acute Myocarditis and Cardiomyopathies

Chapter
First Online:

Abstract

The definition and classification of cardiomyopathies was recently revised by an expert panel of the American Heart Association [1] following the initial classification by the World Health Organization in 1995 [2]. Cardiomyopathies are considered “a heterogeneous group of diseases of the myocardium associated with mechanical and/or electrical dysfunction that usually (but not invariably) exhibit inappropriate ventricular hypertrophy or dilatation and are due to a variety of causes that frequently are genetic” [1]. Cardiomyopathies are generally considered as primary (disease solely or predominantly confined to heart muscle) or secondary, showing pathological myocardial involvement secondary to a systemic or multiorgan disease process. Both forms are commonly seen in children, although primary forms predominate.

Keywords

Acute Heart Failure Hypoplastic Left Heart Syndrome Constrictive Pericarditis Ventricular Assist Device Noonan Syndrome 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
This is a preview of subscription content, log in to check access.

References

  1. 1.
    Maron BJ, Towbin JA, Thiene G, et al. Contemporary definitions and classification of the cardiomyopathies: an American Heart Association Scientific Statement from the Council on Clinical Cardiology, Heart Failure and Transplantation Committee; Quality of Care and Outcomes Research and Functional Genomics and Translational Biology Interdisciplinary Working Groups; and Council on Epidemiology and Prevention. Circulation. 2006;113:1807–1816.PubMedCrossRefGoogle Scholar
  2. 2.
    Richardson P, McKenna W, Bristow M, et al. Report of the 1995 World Health Organization/International Society and Federation of Cardiology Task Force on the Definition and Classification of cardiomyopathies. Circulation. 1996;93:841–842.PubMedCrossRefGoogle Scholar
  3. 3.
    Canter CE, Naftel DC. Recipient characteristics. In: Fine RN, Webber SA, Olthoff KM, Kelly DA, Harmon WE, eds. Pediatric Solid Organ Transplantation. Malden, MA: Blackwell Publishing, Ltd.; 2007:259–264.CrossRefGoogle Scholar
  4. 4.
    Blume ED, Naftel DC, Bastardi HJ, et al. Outcomes of children bridged to heart transplantation with ventricular assist devices: a multi-institutional study. Circulation. 2006;113:2313–2319.PubMedCrossRefGoogle Scholar
  5. 5.
    Lipshultz SE, Sleeper LA, Towbin JA, et al. The incidence of pediatric cardiomyopathy in two regions of the United States. N Engl J Med. 2003;348:1647–1655.PubMedCrossRefGoogle Scholar
  6. 6.
    Nugent AW, Daubeney PEF, Chondros P, et al. The epidemiology of childhood cardiomyopathy in Australia. N Engl J Med. 2003;348:1639–1646.PubMedCrossRefGoogle Scholar
  7. 7.
    Rasten-Almqvist P, Eksborg S, Rajs J. Heart weight in infants – a comparison between sudden infant death syndrome and other causes of death. Acta Paediatr. 2000;89:1062–1067.PubMedCrossRefGoogle Scholar
  8. 8.
    Martino TA, Liu P, Sole MJ. Viral infection and the pathogenesis of dilated cardiomyopathy. Circ Res. 1994;74:182–188.PubMedCrossRefGoogle Scholar
  9. 9.
    Fujioka S, Kitaura Y, Ukimura A, et al. Evaluation of viral infection in the myocardium of patients with idiopathic dilated cardiomyopathy. J Am Coll Cardiol. 2000;36:1920–1926.PubMedCrossRefGoogle Scholar
  10. 10.
    Fujioka S, Kitaura Y, Deguchi H, et al. Evidence of viral infection in the myocardium of American and Japanese patients with idiopathic dilated cardiomyopathy. Am J Cardiol. 2004;94:602–605.PubMedCrossRefGoogle Scholar
  11. 11.
    Martin AB, Webber S, Fricker FJ, et al. Acute myocarditis. Rapid diagnosis by PCR in children. Circulation. 1994;90:330–339.PubMedCrossRefGoogle Scholar
  12. 12.
    Towbin JA, Bowles KR, Bowles NE. Etiologies of cardiomyopathy and heart failure. Nat Med. 1999;5:266–267.PubMedCrossRefGoogle Scholar
  13. 13.
    Menon SC, Olson TM, Michels VV. Genetics of familial dilated cardiomyopathy. Prog Pediatr Cardiol. 2008;25:57–67.CrossRefGoogle Scholar
  14. 14.
    Mohapatra B, Jimenez S, Lin JH, et al. Mutations in the muscle LIM protein and alpha-actinin-2 genes in dilated cardiomyopathy and endocardial fibroelastosis. Mol Genet Metab. 2003;80:207–215.PubMedCrossRefGoogle Scholar
  15. 15.
    Cox GF. Diagnostic approaches to pediatric cardiomyopathy of metabolic genetic etiologies and their relation to therapy. Prog Pediatr Cardiol. 2007;24:15–25.PubMedCrossRefGoogle Scholar
  16. 16.
    Pophal SG, Sigfusson G, Booth KL, et al. Complications of endomyocardial biopsy in children. J Am Coll Cardiol. 1999;34:2105–2110.PubMedCrossRefGoogle Scholar
  17. 17.
    Aretz HT, Billingham ME, Edwards WD, et al. Myocarditis. A histopathologic definition and classification. Am J Cardiovasc Pathol. 1987;1:3–14.PubMedGoogle Scholar
  18. 18.
    Kishnani PS, BurnsWechsler S, Li JS. Enzyme-deficiency metabolic cardiomyopathies and the role of enzyme replacement therapy. Prog Pediatr Cardiol. 2007;23:39–48.CrossRefGoogle Scholar
  19. 19.
    Hill KD, Hamid R, Exil VJ. Pediatric cardiomyopathies related to fatty acid metabolism. Prog Pediatr Cardiol. 2008;25:69–78.CrossRefGoogle Scholar
  20. 20.
    Feingold B, Law YM. Nesiritide use in pediatric patients with congestive heart failure. J Heart Lung Transplant. 2004;23:1455–1459.PubMedCrossRefGoogle Scholar
  21. 21.
    Simsic JM, Scheurer M, Tobias JD, et al. Perioperative effects and safety of nesiritide following cardiac surgery in children. J Intensive Care Med. 2006;21:22–26.PubMedCrossRefGoogle Scholar
  22. 22.
    Shaddy RE, Boucek MM, Hsu DT, et al. Carvedilol for children and adolescents with heart failure: a randomized controlled trial. JAMA. 2007;298:1171–1179.PubMedCrossRefGoogle Scholar
  23. 23.
    English RF, Janosky JE, Ettedgui JA, Webber SA. Outcomes for children with acute myocarditis. Cardiol Young. 2004;14:488–493.PubMedCrossRefGoogle Scholar
  24. 24.
    Rhee EK, Canter CE, Basile S, Webber SA, Naftel DC. Sudden death prior to pediatric heart transplantation: would implantable defibrillators improve outcome? J Heart Lung Transplant. 2007;26:447–452.PubMedCrossRefGoogle Scholar
  25. 25.
    Korte T, Koditz H, Niehaus M, Paul T, Tebbenjohanns J. High incidence of appropriate and inappropriate ICD therapies in children and adolescents with implantable cardioverter defibrillator. Pacing Clin Electrophysiol. 2004;27:924–932.PubMedCrossRefGoogle Scholar
  26. 26.
    Daubeney PEF, Nugent AW, Chondros P, et al. Clinical features and outcomes of childhood dilated cardiomyopathy: results from a national population-based study. Circulation. 2006;114:2671–2678.PubMedCrossRefGoogle Scholar
  27. 27.
    Weintraub RG, Nugent AW, Daubeney PEF. Pediatric cardiomyopathy: the Australian experience. Prog Pediatr Cardiol. 2007;23:17–24.CrossRefGoogle Scholar
  28. 28.
    Towbin JA, Lowe AM, Colan SD, et al. Incidence, causes, and outcomes of dilated cardiomyopathy in children. JAMA. 2006;296:1867–1876.PubMedCrossRefGoogle Scholar
  29. 29.
    Wilkinson JD, Sleeper LA, Alvarez JA, Bublik N, Lipshultz SE. The Pediatric Cardiomyopathy Registry: 1995–2007. Prog Pediatr Cardiol. 2008;25:31–36.PubMedCrossRefGoogle Scholar
  30. 30.
    Andrews RE, Fenton MJ, Ridout DA, Burch M, British Congenital Cardiac Association. New-onset heart failure due to heart muscle disease in childhood: a prospective study in the United Kingdom and Ireland. Circulation. 2008;117:79–84.PubMedCrossRefGoogle Scholar
  31. 31.
    Alvarez JA, Wilkinson JD, Lipshultz SE. Outcome predictors for pediatric dilated cardiomyopathy: a systematic review. Prog Pediatr Cardiol. 2007;23:25–32.PubMedCrossRefGoogle Scholar
  32. 32.
    Maron BJ. Hypertrophic cardiomyopathy in childhood. Pediatr Clin North Am. 2004;51:1305–1346.PubMedCrossRefGoogle Scholar
  33. 33.
    Kubo T, Gimeno JR, Bahl A, et al. Prevalence, clinical significance, and genetic basis of hypertrophic cardiomyopathy with restrictive phenotype. J Am Coll Cardiol. 2007;49:2419–2426.PubMedCrossRefGoogle Scholar
  34. 34.
    Mogensen J, Kubo T, Duque M, et al. Idiopathic restrictive cardiomyopathy is part of the clinical expression of cardiac troponin I mutations. J Clin Invest. 2003;111:209–216.PubMedGoogle Scholar
  35. 35.
    Maron BJ. Hypertrophic cardiomyopathy. Lancet. 1997;350:127–133.PubMedCrossRefGoogle Scholar
  36. 36.
    Dipchand AI, Naftel DC, Feingold B, et al. Outcomes of children with cardiomyopathy listed for transplant: a multi-institutional study. J Heart Lung Transplant. 2009; doi:10.1016/j.healun.2009.05.019.Google Scholar
  37. 37.
    Yano M, Kohno M, Ohkusa T, et al. Effect of milrinone on left ventricular relaxation and Ca(2+) uptake function of cardiac sarcoplasmic reticulum. Am J Physiol Heart Circ Physiol. 2000;279:H1898–H1905.PubMedGoogle Scholar
  38. 38.
    Berul CI, Van Hare GF, Kertesz NJ, et al. Results of a multicenter retrospective implantable cardioverter-defibrillator registry of pediatric and congenital heart disease patients. J Am Coll Cardiol. 2008;51:1685–1691.PubMedCrossRefGoogle Scholar
  39. 39.
    Towbin JA. Pediatric myocardial disease. Pediatr Clin North Am. 1999;46:289–312.PubMedCrossRefGoogle Scholar
  40. 40.
    Maron BJ, Spirito P. Implications of left ventricular remodeling in hypertrophic cardiomyopathy. Am J Cardiol. 1998;81:1339–1344.PubMedCrossRefGoogle Scholar
  41. 41.
    Nugent AW, Daubeney PEF, Chondros P, et al. Clinical features and outcomes of childhood hypertrophic cardiomyopathy: results from a national population-based study. Circulation. 2005;112:1332–1338.PubMedCrossRefGoogle Scholar
  42. 42.
    Colan SD, Lipshultz SE, Lowe AM, et al. Epidemiology and cause-specific outcome of hypertrophic cardiomyopathy in children: findings from the Pediatric Cardiomyopathy Registry. Circulation. 2007;115:773–781.PubMedCrossRefGoogle Scholar
  43. 43.
    Russo LM, Webber SA. Idiopathic restrictive cardiomyopathy in children. Heart. 2005;91:1199–1202.PubMedCrossRefGoogle Scholar
  44. 44.
    Rivenes SM, Kearney DL, Smith EO, Towbin JA, Denfield SW. Sudden death and cardiovascular collapse in children with restrictive cardiomyopathy. Circulation. 2000;102:876–882.PubMedCrossRefGoogle Scholar
  45. 45.
    Chen SC, Balfour IC, Jureidini S. Clinical spectrum of restrictive cardiomyopathy in children. J Heart Lung Transplant. 2001;20:90–92.PubMedCrossRefGoogle Scholar
  46. 46.
    Denfield SW, Rosenthal G, Gajarski RJ, et al. Restrictive cardiomyopathies in childhood. Etiologies and natural history. Tex Heart Inst J. 1997;24:38–44.PubMedGoogle Scholar
  47. 47.
    Weller RJ, Weintraub R, Addonizio LJ, Chrisant MRK, Gersony WM, Hsu DT. Outcome of idiopathic restrictive cardiomyopathy in children. Am J Cardiol. 2002;90:501–506.PubMedCrossRefGoogle Scholar
  48. 48.
    Kimberling MT, Balzer DT, Hirsch R, Mendeloff E, Huddleston CB, Canter CE. Cardiac transplantation for pediatric restrictive cardiomyopathy: presentation, evaluation, and short-term outcome. J Heart Lung Transplant. 2002;21:455–459.PubMedCrossRefGoogle Scholar
  49. 49.
    Cetta F, O’Leary PW, Seward JB, Driscoll DJ. Idiopathic restrictive cardiomyopathy in childhood: diagnostic features and clinical course. Mayo Clin Proc. 1995;70:634–640.PubMedCrossRefGoogle Scholar
  50. 50.
    Pignatelli RH, McMahon CJ, Dreyer WJ, et al. Clinical characterization of left ventricular noncompaction in children: a relatively common form of cardiomyopathy. Circulation. 2003;108:2672–2678.PubMedCrossRefGoogle Scholar
  51. 51.
    Towbin JA, Bowles NE. The failing heart. Nature. 2002;415:227–233.PubMedCrossRefGoogle Scholar
  52. 52.
    Bleyl SB, Mumford BR, Brown-Harrison MC, et al. Xq28-linked noncompaction of the left ventricular myocardium: prenatal diagnosis and pathologic analysis of affected individuals. Am J Med Genet. 1997;72:257–265.PubMedCrossRefGoogle Scholar
  53. 53.
    Spencer CT, Bryant RM, Day J, et al. Cardiac and clinical phenotype in Barth syndrome. Pediatrics. 2006;118:e337–e346.PubMedCrossRefGoogle Scholar
  54. 54.
    D’Adamo P, Fassone L, Gedeon A, et al. The X-linked gene G4.5 is responsible for different infantile dilated cardiomyopathies. Am J Hum Genet. 1997;61:862–867.PubMedCrossRefGoogle Scholar
  55. 55.
    Weiford BC, Subbarao VD, Mulhern KM. Noncompaction of the ventricular myocardium. Circulation. 2004;109:2965–2971.PubMedCrossRefGoogle Scholar
  56. 56.
    Ritter M, Oechslin E, Sutsch G, Attenhofer C, Schneider J, Jenni R. Isolated noncompaction of the myocardium in adults. Mayo Clin Proc. 1997;72:26–31.PubMedCrossRefGoogle Scholar
  57. 57.
    Oechslin EN, Attenhofer Jost CH, Rojas JR, Kaufmann PA, Jenni R. Long-term follow-up of 34 adults with isolated left ventricular noncompaction: a distinct cardiomyopathy with poor prognosis. J Am Coll Cardiol. 2000;36:493–500.PubMedCrossRefGoogle Scholar
  58. 58.
    Chin TK, Perloff JK, Williams RG, Jue K, Mohrmann R. Isolated noncompaction of left ventricular myocardium. A study of eight cases. Circulation. 1990;82:507–513.PubMedCrossRefGoogle Scholar
  59. 59.
    Ichida F, Hamamichi Y, Miyawaki T, et al. Clinical features of isolated noncompaction of the ventricular myocardium: long-term clinical course, hemodynamic properties, and genetic background. J Am Coll Cardiol. 1999;34:233–240.PubMedCrossRefGoogle Scholar
  60. 60.
    Jenni R, Oechslin E, Schneider J, Attenhofer Jost C, Kaufmann PA. Echocardiographic and pathoanatomical characteristics of isolated left ventricular non-compaction: a step towards classification as a distinct cardiomyopathy. Heart. 2001;86:666–671.PubMedCrossRefGoogle Scholar
  61. 61.
    Kohli SK, Pantazis AA, Shah JS, et al. Diagnosis of left-ventricular non-compaction in patients with left-ventricular systolic dysfunction: time for a reappraisal of diagnostic criteria? Eur Heart J. 2008;29:89–95.PubMedCrossRefGoogle Scholar
  62. 62.
    Soler R, Rodriguez E, Monserrat L, Alvarez N. MRI of subendocardial perfusion deficits in isolated left ventricular noncompaction. J Comput Assist Tomogr. 2002;26:373–375.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag London Limited 2009

Authors and Affiliations

  1. 1.CardiologyChildren’s Hospital of Pittsburgh of UPMC, University of Pittsburgh, School of MedicinePittsburghUSA

Personalised recommendations